Format

Send to

Choose Destination
Vaccine. 2007 Nov 23;25(48):8172-9. Epub 2007 Oct 2.

Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine.

Author information

1
Sanofi Pasteur Limited, 1755 Steeles Avenue West, Toronto, Ontario M2R 3T4, Canada. luis.barreto@sanofipasteur.com

Abstract

Persistence of antibodies following a single dose of Tdap vaccine (tetanus, diphtheria, and five-component acellular pertussis vaccine for use in individuals past childhood) was evaluated in a follow-up of adolescents (N=324) and adults (N=644) who had received Tdap in earlier clinical trials. Outcome measures were seroprotection (tetanus and diphtheria) or seropositivity (pertussis) and geometric mean titers. Humoral immune responses to all antigens were robust 1 month after initial immunization; antibodies exceeded pre-immunization levels 1, 3, and 5 years later. These data will contribute to selecting the optimal interval for booster doses of Tdap.

PMID:
17945400
DOI:
10.1016/j.vaccine.2007.09.031
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center